Executive Summary The use of Precision Medicine (PM) is increasing across Asia at a pace that outstrips the capacity of existing Health Technology Assessment (HTA) and reimbursement systems to respond. The “Workshop on Paying for Precision Medicine Sustainably in Asia: Reimbursement Barriers, Ena

EXECUTIVE SUMMARY  The Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand, undertook a mission to Colombo, Sri Lanka, supported by the World Bank Group. The mission aimed to support national efforts to strengthen capacity on health priority setting and institutiona

Abstract Understanding the financial and health consequences if economic evaluation assumptions prove incorrect is essential for managing the risk associated with benefit package decisions, particularly in resource-constrained and overburdened healthcare systems. Yet these are also the settings t

Welcome to HTAsiaLink Newsletter, Volume 21!  This year, our network has continued to grow, work together, and share knowledge. From research exchanges and capacity-building activities to policy discussions, our members have shown what can be achieved when we move forward together.  The theme

This report provides an overview of regional efforts to strengthen HTA capacity across Southeast Asia under the Association of Southeast Asian Nations (ASEAN) Health Cluster 3 (AHC 3) Work Programme. Led by Health Intervention and Technology Assessment Program Foundation (HITAP), in collaboration

Abstract Surrogate endpoints are frequently used as primary outcomes in clinical trials. This is appropriate when they are validated for their ability to predict clinical benefit measured on patient-relevant target outcome(s). Such validation is often lacking, thus increasing uncertainty in the dec

Although HITAP strictly follows national HTA methodological guidelines, questions over the good governance of research arose from a lack of formal process guidelines. Therefore, HITAP embarked on the development of HTA process guidelines in 2011. International guidelines were reviewed in order to develop a conceptual framework, with the aim of conn

201-369-2555HITA,HITAP,HTA,method guidelines,การประเมินความคุ้มค่าด้านสุขภาพ

คู่มือการประเมินเทคโนโลยีด้านสุขภาพสำหรับประเทศไทย ฉบับที่ 1 (พ.ศ. 2551) ได้รับการพัฒนาขึ้นเพื่อเป็นแนวทางมาตรฐานในการวิเคราะห

HTAsiaLink is a collaborative research network of Health Technology Assessment (HTA) agencies in the Asia-Pacific region established on September 2010. The network started with an aim to strengthen Health Technology Assessment (HTA) research efficiency by sharing HTA information, experiences, and resources within the members. HTAsiaLink also focuse